Amneal Pharmaceuticals Inc (AMRX)

12:18 PM

Do Options Traders Know Something About Amneal Stock We Don't? - Yahoo Finance

12:18 PM

08:14 AM

How The Amneal Pharmaceuticals (AMRX) Story Is Shifting Around The New US$17 Price Target - Yahoo Finance

08:14 AM

05:12 AM

Earnings call transcript: Amneal Pharma Q1 2026 Surpasses EPS Forecast By Investing.com - Investing.com Canada

05:12 AM

05:07 AM

Earnings call transcript: Amneal Pharma Q1 2026 Surpasses EPS Forecast - Investing.com

05:07 AM

May 04, 2026

Amneal (AMRX) Q3 2025 Earnings Call Transcript - AOL.com

May 04, 2026

May 04, 2026

Amneal Pharmaceuticals Q1 2026 earnings preview - MSN

May 04, 2026

May 04, 2026

How CREXONT’s Positive Phase 4 Data and Reaffirmed Outlook Could Shape Amneal Pharmaceuticals (AMRX) Investors - Sahm

May 04, 2026

May 04, 2026

AMRX growth drivers: Generics, biosimilars, and Crexont - MSN

May 04, 2026

May 03, 2026

3 Biotech Stocks to Watch for Respectable Growth Beyond AI - AOL.com

May 03, 2026

May 03, 2026

Artemis Investment Management LLP Buys Shares of 124,899 Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

May 03, 2026

May 03, 2026

Wall Street analysts see a 34.77% upside in Amneal (AMRX): Can the stock really move this high? - MSN

May 03, 2026

May 01, 2026

Amneal (AMRX) Q1 2026 Earnings Transcript - The Globe and Mail

May 01, 2026

May 01, 2026

Earnings Scheduled For May 1, 2026 - Benzinga

May 01, 2026

May 01, 2026

UBS Initiates Coverage of Amneal Pharmaceuticals (AMRX) With a Bullish Outlook - Yahoo Finance

May 01, 2026

May 01, 2026

Here's how AMRX is tapping GLP-1 demand through manufacturing - MSN

May 01, 2026

Apr 30, 2026

Amneal to buy Kashiv in $750M deal; raises FY26 EPS outlook - MSN

Apr 30, 2026

Apr 30, 2026

Amneal Q1 2026 slides: $750M Kashiv deal creates biosimilar leader - Investing.com India

Apr 30, 2026

Apr 30, 2026

Earnings call transcript: Amneal Pharma Q1 2026 beats EPS forecast By Investing.com - Investing.com India

Apr 30, 2026

Apr 30, 2026

Amneal (AMRX) Q1 earnings report preview: What to look for - MSN

Apr 30, 2026

Apr 30, 2026

Is It Too Late To Reassess Amneal Pharmaceuticals (AMRX) After Its 65% One-Year Surge? - simplywall.st

Apr 30, 2026

Apr 30, 2026

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update - MarketBeat

Apr 30, 2026

Apr 29, 2026

Amneal (AMRX) Q1 Earnings Report Preview: What To Look For - StockStory

Apr 29, 2026

Apr 29, 2026

Amneal Pharma to acquire Kashiv BioSciences to create fully integrated global biosimilar leader - MSN

Apr 29, 2026

Apr 29, 2026

AMRX: 3 growth drivers behind Amneal's 2026 outlook - MSN

Apr 29, 2026

Apr 29, 2026

Here's why Amneal Pharmaceuticals (AMRX) is a strong growth stock - MSN

Apr 29, 2026

Apr 29, 2026

Amneal Pharmaceuticals (AMRX) is a top-ranked momentum stock: Should you buy? - MSN

Apr 29, 2026

Apr 29, 2026

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High? - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 29, 2026

Apr 29, 2026

AMRX Should I Buy - Intellectia AI

Apr 29, 2026

Apr 28, 2026

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 - Quantisnow

Apr 28, 2026

Apr 28, 2026

Amneal 2026-2027 Upside From Biosimilars Scale - Zacks Investment Research

Apr 28, 2026

Apr 28, 2026

AMRX Valuation: What 1.69x Sales Means for Investors - Yahoo Finance

Apr 28, 2026

Apr 28, 2026

AMRX Growth Drivers: Generics, Biosimilars, and Crexont - Yahoo Finance

Apr 28, 2026

Apr 27, 2026

BlackRock (NYSE: AMRX) holds 24.1M shares, 7.6% stake reported - Stock Titan

Apr 27, 2026

Apr 27, 2026

Here's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth Stock - Yahoo Finance

Apr 27, 2026